HLLY vs TSLA

HLLY presents a complex profile where strong defensive valuation metrics clash with poor operational execution. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $3.37 sits comfortably below the Graham Number ($3.69) but significantly above the growth-based Intrinsic Value ($1.12). While the company outperforms its sector in profitability and maintains a strong current ratio, a disastrous earnings track record (0/4 beats in the last year) and negative YoY EPS growth (-63.6%) create significant headwinds. The stock appears undervalued on a book and sales basis, but lacks the fundamental momentum to justify a bullish rating.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.